Search
Close this search box.
News

Latest Industry Updates

From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.

UK Regulator Cites CluePoints’ Solutions in Updated Guidance
King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx)...
Read
CluePoints Senior Vice President, Europe, and APAC, to Speak at SCOPE 2022
John Hall, Senior Vice President, EU, and APAC, at CluePoints, will share insights into delivering successful...
Read
Risk-Based Quality Management Perfect for DCTS
A leader from the RBQM solutions specialists offers a preview of his SCOPE 2022 presentation on tools...
Read
Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring
A central statistical assessment of the quality of data collected in clinical trials can improve the...
Read
Unlocking the Potential of Risk-Based Quality Monitoring
Risk-Based Quality Management (RBQM) and Risk-Based Monitoring (RBM) are shifting the clinical research...
Read
HiRO and CluePoints Partnership Offers Market-Leading RBQM Opportunities in China
King of Prussia, PA: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research...
Read
1 12 13 14 15 16 29
CluePoints Appoints Steve Young As Senior Vice President Of US Operations

Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...

CluePoints CEO, François Torche, Honored In PharmaVOICE 100

Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has...

CluePoints Risk-Based Monitoring Platform (Version 1.9.0) Is Live!

We’re thrilled to announce that CluePoints’ latest version (1.9.0) of the Central Monitoring platform is live!...

CluePoints Founder, Marc Buyse To Deliver Clinical Trial Data Quality Course At The ASA Biopharmaceutical Workshop

The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop is fast approaching and we’re thrilled to announce that...

Unveiling CluePoints’ New And Improved Risk-Based Monitoring Software

Today, we’re thrilled to unveil CluePoints’ latest release of its award-winning Risk-Based Monitoring Software. For this...

CluePoints Announce 2nd Annual Risk-Based Monitoring Roadshows To Take Place In Basel, Switzerland & Cambridge, UK

Join CluePoints CEO Francois Torche and OmniComm Sr. Director Steve Young at this special thought leadership...

CluePoints Named Clinical Research & Excellence Awards Finalist

Awards recognize CluePoints’ Risk-Based Monitoring solution in the ‘Best Sponsor-Focused Technological Development’ category. Cambridge, MA –...

CluePoints And Widler & Schiemann Collaborate On Complete Risk-Management Solution For Clinical Trials In Line With New Industry Guidance

Partnership will combine CluePoints’ Risk-Based Monitoring Software with Widler & Schiemann’s Consultancy Services Cambridge, MA –...

CluePoints Partners with OmniComm Systems® to Offer Collective Risk-Based Monitoring & Electronic Data Capture Solution

Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...

CluePoints Announces Partnership with Bracket for CNS Trials

Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...

CluePoints Chief Commercial Officer Named in PharmaVOICE 100

Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials,...

CluePoints Receives € 6million Growth Investment

Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...

None found. Please check back later!
None found. Please check back later!